LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis.

Yi-Ling ChenYi-Nan LiuYen-Ting LinMeng-Feng TsaiShang-Gin WuTzu-Hua ChangChia-Lang HsuHuey-Dong WuJin-Yuan Shih

Published in: Journal of biomedical science (2023)

These findings demonstrated that SLCO4A1-AS1 antagonizes TOX4/NTSR1 signaling, underscoring its pivotal role in lung cancer cell migration and invasion. These findings hold promise for the development of novel therapeutic strategies targeting the SLCO4A1-AS1/TOX4/NTSR1 axis as a potential avenue for effective therapeutic intervention in lung cancer.

Keyphrases

randomized controlled trial
signaling pathway
long non coding rna
cancer therapy
big data
long noncoding rna
climate change